Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China · Delayed Price · Currency is CNY 203.83
-1.97 (-0.96%)
Jul 25, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Liver Disease Medication | 4.46B | Log In | Log In | Log In | Log In | Upgrade |
Liver Disease Medication Growth | 24.26% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Circulation | 4.20B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Circulation Growth | 3.60% | Log In | Log In | Log In | Log In | Upgrade |
Cosmetics | 706.76M | Log In | Log In | Log In | Log In | Upgrade |
Cosmetics Growth | 11.42% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Medication | 265.75M | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Medication Growth | 60.57% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 22.31M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | 14.28% | Log In | Log In | Log In | Log In | Upgrade |
Other | 395.59M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 76.53% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cosmetics and Daily Chemical | - | Log In | Log In | Log In | Log In | Upgrade |
Cosmetics and Daily Chemical Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Food | - | Log In | Log In | Log In | Log In | Upgrade |
Food Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System Medication | - | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System Medication Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Dermatology Medication | - | Log In | Log In | Log In | Log In | Upgrade |
Dermatology Medication Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cold Medicine | - | Log In | Log In | Log In | Log In | Upgrade |
Cold Medicine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Orthopedics Medicines | - | Log In | Log In | Log In | Log In | Upgrade |
Anorectal Medicine | - | Log In | Log In | Log In | Log In | Upgrade |
Anorectal Medicine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 9.60B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 15.78% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 457.64M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 13.95% | Log In | Log In | Log In | Log In | Upgrade |